Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

NCT ID: NCT01908166

Last Updated: 2017-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2016-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results.

OUTLINE:

Patients undergo ultrasound elastography.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult Primary Liver Cancer Kidney Tumor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diagnostic (ultrasound elastography)

Patients undergo ultrasound elastography.

Group Type EXPERIMENTAL

ultrasound elasticity imaging

Intervention Type PROCEDURE

Undergo ultrasound elastography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound elasticity imaging

Undergo ultrasound elastography

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* There are no restrictions on life expectancy
* Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed
* Patients of any ethnic background
* Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria

* Patients should not be taking other investigational agents
* No requirements due to co-morbid disease or intercurrent illness, as needed
* No restrictions on allergic reactions as no imaging agent will be used
* Concomitant medications for treatment of the target lesion
* Pregnant or nursing patients will be excluded from the study
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Juergen Willmann

Professor of Radiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juergen Willmann

Role: PRINCIPAL_INVESTIGATOR

Stanford University Hospitals and Clinics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University, School of Medicine

Stanford, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2013-01353

Identifier Type: REGISTRY

Identifier Source: secondary_id

P30CA124435

Identifier Type: NIH

Identifier Source: secondary_id

View Link

VAR0099

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.